WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |

Search International and National Patent Collections
World Intellectual Property Organization
Machine translation
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/119107    International Application No.:    PCT/US2006/016441
Publication Date: 09.11.2006 International Filing Date: 28.04.2006
C07K 14/51 (2006.01), C07K 16/18 (2006.01)
Applicants: UCB PHARMA S.A. [BE/BE]; Allée de la Recherche 60, B-1070 Brussels (BE) (For All Designated States Except US).
AMGEN INC. [US/US]; One Amgen Center Drive, Thousand Oaks, California 91320 (US) (For All Designated States Except US).
PASZTY, Christopher [US/US]; (US) (For US Only).
ROBINSON, Martyn, Kim [GB/GB]; (GB) (For US Only).
GRAHAM, Kevin [US/US]; (US) (For US Only).
HENRY, Alistair, James [GB/GB]; (GB) (For US Only).
HOFFMANN, Kelly, Sue [US/US]; (US) (For US Only).
LATHAM, John [US/US]; (US) (For US Only).
LAWSON, Alastair [GB/GB]; (GB) (For US Only).
LU, Hsieng, Sen [US/US]; (US) (For US Only).
POPPLEWELL, Andy [GB/GB]; (GB) (For US Only).
SHEN, Wenyan [CA/US]; (US) (For US Only).
WINKLER, David [US/US]; (US) (For US Only).
WINTERS, Aaron, George [US/US]; (US) (For US Only)
Inventors: PASZTY, Christopher; (US).
ROBINSON, Martyn, Kim; (GB).
GRAHAM, Kevin; (US).
HENRY, Alistair, James; (GB).
HOFFMANN, Kelly, Sue; (US).
LATHAM, John; (US).
LAWSON, Alastair; (GB).
LU, Hsieng, Sen; (US).
SHEN, Wenyan; (US).
WINKLER, David; (US).
WINTERS, Aaron, George; (US)
Agent: NEVILLE, Katherine; Marshall, Gerstein & Borun LLP, 6300 Sears Tower, 233 S. Wacker Dr., Chicago, Illinois 60606 (US)
Priority Data:
60/677,583 03.05.2005 US
60/776,847 24.02.2006 US
60/782,244 13.03.2006 US
60/792,645 17.04.2006 US
11/411,003 25.04.2006 US
Abstract: front page image
(EN)Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.
(FR)L'invention concerne des compositions et des procédés ayant trait aux épitopes de la protéine sclérostine, et des agents de fixation à la sclérostine tels que des anticorps pouvant se fixer à la sclérostine.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)